Geode Capital Management LLC Buys 304,426 Shares of Colgate-Palmolive Company $CL

Geode Capital Management LLC raised its stake in Colgate-Palmolive Company (NYSE:CLFree Report) by 1.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,103,901 shares of the company’s stock after acquiring an additional 304,426 shares during the quarter. Geode Capital Management LLC owned about 2.74% of Colgate-Palmolive worth $1,754,657,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. HighPoint Advisor Group LLC raised its holdings in Colgate-Palmolive by 0.7% in the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after acquiring an additional 109 shares during the period. Sunpointe LLC raised its holdings in Colgate-Palmolive by 4.0% in the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after acquiring an additional 117 shares during the period. Capital Advisors Inc. OK raised its holdings in Colgate-Palmolive by 1.4% in the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock valued at $758,000 after acquiring an additional 129 shares during the period. Stratos Wealth Advisors LLC raised its holdings in Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after acquiring an additional 130 shares during the period. Finally, CYBER HORNET ETFs LLC raised its holdings in Colgate-Palmolive by 5.9% in the 4th quarter. CYBER HORNET ETFs LLC now owns 2,357 shares of the company’s stock valued at $186,000 after acquiring an additional 131 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Up 0.4%

Shares of CL opened at $91.69 on Friday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm’s 50 day moving average is $86.24 and its 200-day moving average is $85.60. The stock has a market capitalization of $73.37 billion, a PE ratio of 35.68, a P/E/G ratio of 4.74 and a beta of 0.31. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted $0.91 EPS. Equities research analysts forecast that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were given a dividend of $0.53 per share. The ex-dividend date was Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analyst Upgrades and Downgrades

CL has been the topic of several research analyst reports. Barclays increased their price target on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, May 5th. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, May 4th. Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Jefferies Financial Group raised their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Finally, TD Cowen reaffirmed a “hold” rating and set a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Twelve analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $95.88.

Get Our Latest Stock Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.